CTT Pharmaceutical Holdings Inc CTTH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.00–0.10
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $2.06 Mil
- Volume/Avg
- 2,200 / 18,660
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The company's technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
Valuation
|
Metric
|
CTTH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CTTH
Financial Strength
|
Metric
|
CTTH
|
|---|---|
Quick Ratio | 3.40 |
Current Ratio | 3.40 |
Interest Coverage | — |
Quick Ratio
CTTH
Profitability
|
Metric
|
CTTH
|
|---|---|
Return on Assets (Normalized) | −217.23% |
Return on Equity (Normalized) | −741.62% |
Return on Invested Capital (Normalized) | −741.62% |
Return on Assets
CTTH
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Sqdrglpv | Fqfd | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Drftfjvc | Nlsvrqq | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Kppkvcgl | Ywj | $41.4 Bil | |||
| Viatris Inc
VTRS
| Zzvtnnj | Fsm | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pvjbnxnb | Fwy | $13.7 Bil | |||
| Catalent Inc
CTLT
| Wjcbnxqv | Pgmyhr | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Wgthwkxxt | Lbrw | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Krbxhvtl | Wgkwbm | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Jnzvycq | Rkqg | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Tjwdhprty | Cbz | $2.7 Bil |